Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 9, 2007, Pages 1429-1434

  Oh, Jung Hwan ^a   Choi, Myung Gyu ^a,c   Dong, Mi Sook ^b   Park, Jae Myung ^a   Paik, Chang Nyol ^a   Cho, Yu Kyung ^a   Jeong, Jeong Jo ^a   Lee, In Seok ^a   Kim, Sang Woo ^a   Han, Sok Won ^a   Choi, Kyu Yong ^a   Chung, In Sik ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

CYP2C19; Endoscopic hemostasis; Gastrointestinal hemorrhage; Pantoprazole

Indexed keywords

CYTOCHROME P450 2C19; PANTOPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG OVERDOSE; FEMALE; GASTRIC PH MONITORING; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; GENETIC CORRELATION; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; KOREA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMACH ACID;

EID: 34547972440     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05059.x     Document Type: Article

References (25)

1. Lau JY, Sung JJ, Lee KK et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Engl. J. Med. 2000 343 : 310 16.
2. Soetikno RM, Gotoda T, Nakanishi Y et al. Endoscopic mucosal resection. Gastrointest. Endosc. 2003 57 : 567 79.
3. Green FW Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978 74 : 38 43.
4. Hsieh YH, Lin HJ, Tseng GY et al. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding. Hepatogastroenterology 2004 51 : 316 19.
5. Brunner G, Luna P, Hartmann M et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J. Biol. Med. 1996 69 : 225 31.
6. van Rensburg CJ, Hartmann M, Thorpe A et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am. J. Gastroenterol. 2003 98 : 2635 41.
7. Udd M, Toyry J, Miettinen P et al. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring. Eur. J. Gastroenterol. Hepatol. 2005 17 : 1351 6.
8. Laine L. Treatment of nonvariceal upper GI hemorrhage: what's happening in the real world. Am. J. Gastroenterol. 2004 99 : 1247 9.
9. Daneshmend TK, Hawkey CJ, Langman MJ et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992 304 : 143 7.
10. Schaffalitzky de Muckadell OB, Havelund T, Harling H et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand. J. Gastroenterol. 1997 32 : 320 27.
11. Lin HJ, Lo WC, Lee FY et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch. Intern. Med. 1998 158 : 54 8.
12. Khuroo MS, Yattoo GN, Javid G et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N. Engl. J. Med. 1997 336 : 1054 8.
13. Javid G, Masoodi I, Zargar SA et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am. J. Med. 2001 111 : 280 84.
14. Kaviani MJ, Hashemi MR, Kazemifar AR et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment. Pharmacol. Ther. 2003 17 : 211 16.
15. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration. Aliment. Pharmacol. Ther. 2005 21 : 1055 61.
16. Goldstein JA, Blaisdell J. Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism. Methods Enzymol. 1996 272 : 210 18.
17. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974 2 : 394 7.
18. Lam SK, Hasan M, Sircus W et al. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980 21 : 324 8.
19. Furuta T, Shirai N, Sugimoto M et al. Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metab. Pharmacokinet. 2005 20 : 153 67.
20. Ishizaki T, Sohn DR, Kobayashi K et al. Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals. Ther. Drug Monit. 1994 16 : 214 15.
21. Kubota T, Chiba K, Ishizaki T. Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population. Clin. Pharmacol. Ther. 1996 60 : 661 6.
22. Watanabe Y, Kato N, Maehata T et al. Safer endoscopic gastric mucosal resection: preoperative proton pump inhibitor administration. J. Gastroenterol. Hepatol. 2006 21 : 1675 80.
23. Ye BD, Cheon JH, Choi KD et al. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. Aliment. Pharmacol. Ther. 2006 24 : 837 43.
24. Labenz J, Tillenburg B, Peitz U et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996 110 : 725 32.
25. Martinek J, Blum AL, Stolte M et al. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 1999 13 : 27 34.